Fund & Portfolio Comparison

Performance Comparison
Comparison Box

Portfolio Performance Comparison
Name YTD Return 1Yr AR 3Yr AR 5Yr AR 10Yr AR 15Yr AR 20Yr AR Common Inception
XDNA (Kelly CRISPR & Gene Editing Technology ETF) NA -519,889.21% NA NA NA NA NA
Data as of 01/03/2024, Common starting date is 01/04/2022
More Performance Analytics Comparison
Name Start Date End Date
XDNA (Kelly CRISPR & Gene Editing Technology ETF) 01/04/2022 01/03/2024
Last 1 Week 1 Yr 3 Yr 5 Yr 10 Yr 15 Yr 20 Yr Common Inception 2024 2023 2022
Annualized Return (%) 0.41 -519,889.21 NA NA NA NA NA 0.41 -514,653.41 -33.73
Sharpe Ratio NA 1.26 NA NA NA NA NA NA 1.46 -0.69
Standard Deviation(%) NA 147.76 NA NA NA NA NA 0.00 150.57 51.69
Draw Down(%) NA 436,793.66 NA NA NA NA NA 0.00 435,020.14 41.97
Yield(%) 0.00 74.74 16.43 9.86 4.93 3.29 2.46 0.00 74.74 0.06
Data as of 01/03/2024, Common starting date is 01/04/2022
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
Ticker/Portfolio Name 3 Year 5 Year 10 Year 15 Year
XDNA (Kelly CRISPR & Gene Editing Technology ETF) 0.00%
NA
0.00%
NA
0.00%
NA
0.00%
NA
Annualized Rolling Returns Comparison (Maximum)
Ticker/Portfolio Name 3 Year 5 Year 10 Year 15 Year
XDNA (Kelly CRISPR & Gene Editing Technology ETF) 0.00%
NA
0.00%
NA
0.00%
NA
0.00%
NA
Annualized Rolling Returns Comparison Chart

3-Year Annualized Rolling Return